North American indapamide market is estimated to grow significantly at a CAGR of around 0.3% during the forecast period. The market is mainly growing due to the rising prevalence of hypertension and CVD such as heart strokes, blood pressure, arrhythmias among others. According to the Heart & Stroke Foundation in Canada (2017), 1.6 million fatalities occur every year due to stroke and at least 1.3 million Canadians live with heart disease. Further, the population is also more inclined to the risk of heart strokes. According to WHO, the incidence and prevalence rate of heart attacks are the highest in North America, which is responsible for 700,000 fatalities each year. Moreover, the rate of adoption of advanced techniques is the highest in North America which in turn supports the growth of the market in North America.

Get Sample Copy of North American Indapamide Market at: https://www.omrglobal.com/request-sample/north-american-indapamide-market

The companies which are contributing to the growth of the North American indapamide market include ANI Pharmaceuticals, Inc., Apotex Inc., Sanofi S.A., Teva Pharmaceuticals Industries Ltd., Mylan N.V., and others.

The North American indapamide market is segmented on the basis of product and application. Based on product, the market is bifurcated into 1.25 mg and 2.5 mg. Among these, the market for 1.25 mg medicine held the significant market share owing to the extensive application of the drug in treating high blood pressure or hypertension. Based on the application, the market is segmented into high blood pressure, heart failure, and others. The high blood pressure segment is projected to have significant share in the market.

For More Information, get A full report of North American Indapamide Market is available at: https://www.omrglobal.com/industry-reports/north-american-indapamide-market

Growing incidence of hypertension is contributing to market growth as indapamide drugs are significantly used to treat hypertension while reducing the risk of developing serious heart conditions. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market.

Market Segmentation

North American Indapamide Market by Product

1.25 MG
2.5 MG

North American Indapamide Market by Application

High Blood Pressure
Heart Failure
Others

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/north-american-indapamide-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 7803040404